Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Amwell Reaffirms FY21 Sales Guidance Of $260M-$270M vs $266.21M Est.


Benzinga | May 12, 2021 04:37PM EDT

Amwell Reaffirms FY21 Sales Guidance Of $260M-$270M vs $266.21M Est.

Financial Outlook

For 2021, the company reiterates their previous outlook of:

* Revenue between $260 and $270 million

* AMG visit volume between 1.5 and 1.7 million

* Adjusted EBITDA between ($157) million and ($147) million







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC